United States · FDA National Drug Code directory
Neostigmine Methylsulfate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43598-945_7abc7438-a58a-cc92-8fba-36e92389bf58
- Product NDC
- 43598-945
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Neostigmine Methylsulfate
- Labeler
- Dr.Reddys Laboratories Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220725
- Source listing expiry
- 20261231
Source-listed ingredients
- NEOSTIGMINE METHYLSULFATE — 1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BLISTER PACK in 1 CARTON (43598-945-58) / 1 SYRINGE, GLASS in 1 BLISTER PACK (43598-945-11) / 3 mL in 1 SYRINGE, GLASS · 43598-945-58
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →